Search Results 941-950 of 18364 for Hepatitis b

  1. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  2. Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL) - Mayo Clinic

    Known active Hepatitis B/ Hepatitis C/ HIV infection; Known, uncontrolled CNS metastases or primary CNS lymphoma; Deep vein thrombosis diagnosed within 3 ...

  3. Safusidenib Phase 2 Study in IDH1 Mutant Glioma - Mayo Clinic

    Positive test results for hepatitis B surface (HBs) antigen and/or hepatitis C virus (HCV) antibody. Patients who have tested positive for hepatitis B core (HBc) ...

  4. Patient Stories - Mairead M. Bartley, M.B., B.Ch., B.A.O., M.D. - Mayo Clinic

    Mairead M. Bartley, M.B., B.Ch., B.A.O., M.D. · Geriatrician · Internist.

  5. A Study of Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) - Mayo Clinic

    Participant has presence of Hepatitis B surface antigen at screening. Participant has a positive Hepatitis C antibody or Hepatitis C ribonucleic acid (RNA) ...

  6. Panobinostat and Everolimus in Treating Patients with Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma - Mayo Clinic

    Precursor B lymphoblastic leukemia/lymphoma ... Extranodal marginal zone B ... hepatitis or chronic persistent hepatitis, or uncontrolled infections will be ...

  7. Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid - Mayo Clinic

    Positive hepatitis B surface antigen (HBsAg) at Screening; Positive HCV RNA ... hepatitis), and PBC (ALP ≥2x ULN; AMA, and non-suppurative bile duct ...

  8. A Study of V940 Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002) - Mayo Clinic

    * Participants who are hepatitis B surface antigen (HBsAg) positive are eligible if they have received hepatitis B virus (HBV) antiviral therapy for at ...

  9. A Study to Evaluate Mutanome-directed Immunotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

    Clinical or laboratory history or evidence of Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV) indicating acute or chronic infection. Any psychological ...

  10. cirrhosis Archives - Mayo Clinic News Network

    ... hepatitis infections published 4/23/18; El minuto de Mayo Clinic: El abecé de la hepatitis (The ABCs of hepatitis) ... Lewis Roberts, M.B., Ch.B., Ph.D ...